Literature DB >> 19332531

Campylobacter jejuni-induced activation of dendritic cells involves cooperative signaling through Toll-like receptor 4 (TLR4)-MyD88 and TLR4-TRIF axes.

Vijay A K Rathinam1, Daniel M Appledorn, Kathleen A Hoag, Andrea Amalfitano, Linda S Mansfield.   

Abstract

Campylobacter jejuni is an important cause of human enteritis and has been linked to the development of autoimmune diseases. Recently we showed that infection of murine dendritic cells (DCs) with C. jejuni resulted in DC activation and induction of Campylobacter-specific Th1-effector responses. Toll-like receptor (TLR) signaling through myeloid differentiation factor 88 (MyD88) and/or Toll-interleukin 1 (IL-1) receptor domain-containing adaptor-inducing beta interferon (IFN-beta) (TRIF) is critical in inducing immunity against pathogens. In this study, we investigated the role of TLR2, TLR4, MyD88, and TRIF signaling in C. jejuni-induced inflammatory activation of DCs. DC upregulation of major histocompatibility complex class II and costimulatory molecules after C. jejuni challenge was profoundly impaired by TLR2, TLR4, MyD88, and TRIF deficiencies. Similarly, C. jejuni-induced secretion of IL-12, IL-6, and tumor necrosis factor alpha was significantly inhibited in TLR2(-/-), TLR4(-/-), MyD88(-/-), and TRIF(-/-) DCs compared to that in wild-type DCs; however, the magnitude of inhibition was greater in MyD88(-/-), TRIF(-/-), and TLR4(-/-) DCs than in TLR2(-/-) DCs. Furthermore, C. jejuni induced interferon regulatory factor 3 phosphorylation and IFN-beta secretion by DCs in a TLR4-TRIF-dependent fashion, further demonstrating activation of this pathway by C. jejuni. Importantly, TLR2, TLR4, MyD88, and TRIF deficiencies all markedly impaired the Th1-priming ability of C. jejuni-infected DCs. Thus, our results show that cooperative signaling through the TLR4-MyD88 and TLR4-TRIF axes represents a novel mechanism mediating C. jejuni-induced inflammatory responses of DCs. To our knowledge, such a mechanism has not been demonstrated previously for an intact bacterium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332531      PMCID: PMC2687361          DOI: 10.1128/IAI.01562-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance.

Authors:  Jan Hendrik Niess; Stephan Brand; Xiubin Gu; Limor Landsman; Steffen Jung; Beth A McCormick; Jatin M Vyas; Marianne Boes; Hidde L Ploegh; James G Fox; Dan R Littman; Hans-Christian Reinecker
Journal:  Science       Date:  2005-01-14       Impact factor: 47.728

Review 2.  The yin and yang of type I interferon activity in bacterial infection.

Authors:  Thomas Decker; Mathias Müller; Silvia Stockinger
Journal:  Nat Rev Immunol       Date:  2005-09       Impact factor: 53.106

3.  Campylobacter jejuni induces maturation and cytokine production in human dendritic cells.

Authors:  Lan Hu; Mechelle D Bray; Manuel Osorio; Dennis J Kopecko
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 4.  Pathogen recognition and innate immunity.

Authors:  Shizuo Akira; Satoshi Uematsu; Osamu Takeuchi
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

5.  Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation.

Authors:  Xinshou Ouyang; Hideo Negishi; Rie Takeda; Yasuyuki Fujita; Tadatsugu Taniguchi; Kenya Honda
Journal:  Biochem Biophys Res Commun       Date:  2007-01-25       Impact factor: 3.575

6.  Campylobacter jejuni colonization of mice with limited enteric flora.

Authors:  Christopher Chang; Jeff F Miller
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

7.  Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling contributes to innate immune responses in the lung during Escherichia coli pneumonia.

Authors:  Samithamby Jeyaseelan; Scott K Young; Michael B Fessler; Yuhong Liu; Kenneth C Malcolm; Masahiro Yamamoto; Shizuo Akira; G Scott Worthen
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

8.  A role of Toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta in the host response to Pseudomonas aeruginosa lung infection in mice.

Authors:  Melanie R Power; Bo Li; Masahiro Yamamoto; Shizuo Akira; Tong-Jun Lin
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

Review 9.  Travellers' diarrhoea: contemporary approaches to therapy and prevention.

Authors:  Herbert L DuPont
Journal:  Drugs       Date:  2006       Impact factor: 9.546

10.  A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.

Authors:  Grégory Gautier; Martine Humbert; Florence Deauvieau; Mathieu Scuiller; John Hiscott; Elizabeth E M Bates; Giorgio Trinchieri; Christophe Caux; Pierre Garrone
Journal:  J Exp Med       Date:  2005-04-25       Impact factor: 14.307

View more
  32 in total

1.  Campylobacter jejuni induces extra-intestinal immune responses via Toll-like-receptor-4 signaling in conventional IL-10 deficient mice with chronic colitis.

Authors:  B Otto; L-M Haag; A Fischer; R Plickert; A A Kühl; U B Göbel; M M Heimesaat; S Bereswill
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

2.  Induction of neutrophil extracellular traps by Campylobacter jejuni.

Authors:  Sean Callahan; Ryan S Doster; Joseph W Jackson; Brittni R Kelley; Jennifer A Gaddy; Jeremiah G Johnson
Journal:  Cell Microbiol       Date:  2020-05-21       Impact factor: 3.715

Review 3.  Campylobacter jejuni and associated immune mechanisms: short-term effects and long-term implications for infants in low-income countries.

Authors:  Amanda E Schnee; William A Petri
Journal:  Curr Opin Infect Dis       Date:  2017-06       Impact factor: 4.915

4.  Deciphering the contribution of human meningothelial cells to the inflammatory and antimicrobial response at the meninges.

Authors:  Pierre-Joseph Royer; Andrew J Rogers; Karl G Wooldridge; Patrick Tighe; Jafar Mahdavi; Michael G Rittig; Dlawer Ala'Aldeen
Journal:  Infect Immun       Date:  2013-09-03       Impact factor: 3.441

5.  Campylobacter jejuni lipooligosaccharide sialylation, phosphorylation, and amide/ester linkage modifications fine-tune human Toll-like receptor 4 activation.

Authors:  Holly N Stephenson; Constance M John; Neveda Naz; Ozan Gundogdu; Nick Dorrell; Brendan W Wren; Gary A Jarvis; Mona Bajaj-Elliott
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

6.  Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner.

Authors:  Marieke Bax; Mark L Kuijf; Astrid P Heikema; Wouter van Rijs; Sven C M Bruijns; Juan J García-Vallejo; Paul R Crocker; Bart C Jacobs; Sandra J van Vliet; Yvette van Kooyk
Journal:  Infect Immun       Date:  2011-04-18       Impact factor: 3.441

7.  Murine Models for the Investigation of Colonization Resistance and Innate Immune Responses in Campylobacter Jejuni Infections.

Authors:  Soraya Mousavi; Stefan Bereswill; Markus M Heimesaat
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

8.  TLR4 and TLR21 expression, MIF, IFN-β, MD-2, CD14 activation, and sIgA production in chickens administered with EFAL41 strain challenged with Campylobacter jejuni.

Authors:  Karaffová V; Marcinková E; Bobíková K; Herich R; Revajová V; Stašová D; Kavuľová A; Levkutová M; Levkut M; Lauková A; Ševčíková Z; Levkut M
Journal:  Folia Microbiol (Praha)       Date:  2016-10-03       Impact factor: 2.099

9.  Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus.

Authors:  Nadeem O Kaakoush; Nandan P Deshpande; Si Ming Man; Jose A Burgos-Portugal; Faisal A Khattak; Mark J Raftery; Marc R Wilkins; Hazel M Mitchell
Journal:  Infect Immun       Date:  2014-12-08       Impact factor: 3.441

Review 10.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.